Akkooi, A. C. J. V., Mandala, M., Kicinski, M., Govaerts, A., Hauschild, A., Rutkowski, P., Arenberger, P., Ascierto, P. A., Tomczak, P., Quereux, G., Galitiis, F. D., Dutriaux, C., Gebhardt, C., Kapiteijn, E., Machet, L., Klauck, I., Sansas, B., Lorigan, P., Long, G. V., Eggermont, A. M. (2025). Primary analysis of the EORTC-2139-MG/Columbus-AD trial: A randomized trial of adjuvant encorafenib and binimetinib versus placebo in high-risk stage II melanoma with a BRAF-V600E/K mutation.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.17_suppl.lba9501